Skip to main content
Top
Published in: Diabetologia 10/2004

01-10-2004 | Article

Moderate alcohol intake and markers of inflammation and endothelial dysfunction among diabetic men

Authors: I. Shai, E. B. Rimm, M. B. Schulze, N. Rifai, M. J. Stampfer, F. B. Hu

Published in: Diabetologia | Issue 10/2004

Login to get access

Abstract

Aims/hypothesis

Type 2 diabetes mellitus is characterised by heightened inflammation and endothelial dysfunction. Moderate alcohol intake has been associated with a reduced risk of cardiovascular disease in Type 2 diabetic patients. It remains to be determined whether there is an association between alcohol and inflammation in individuals with diabetes.

Methods

We investigated the relationship between alcohol intake and inflammation in 726 of 18,159 men who returned blood samples in the Health Professionals Follow-up Study and had confirmed Type 2 diabetes at blood draw.

Results

In age-adjusted analyses, alcohol intake was associated with lower levels of HbA1c, fibrinogen, soluble tumour necrosis factor receptor-2 (sTNF-R2) and soluble vascular adhesion molecule-1 (sVCAM-1), and with higher levels of HDL cholesterol and adiponectin (p value for trends <0.05). After adjustment for age, HbA1c, insulin use, fasting status, smoking, BMI, physical activity, aspirin use, prevalence of cardiovascular disease and dietary factors, each additional drink per day was related to increased HDL cholesterol (0.053 mmol/l, p<0.0001) and adiponectin (0.8 µg/ml, p=0.01), and decreased sTNFR-2 (73 pg/ml, p=0.03), fibrinogen (0.302 µmol/l, p=0.02) and sVCAM-1 (33 ng/ml, p=0.02). The relationship between alcohol and inflammatory biomarkers persisted when subjects were stratified according to HbA1c levels.

Conclusions/interpretation

Moderate alcohol intake may have a beneficial effect on markers of inflammation and endothelial dysfunction in Type 2 diabetic patients.
Literature
1.
go back to reference Pickup JC, Mattock MB, Chusney GD, Burt D (1997) NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 40:1286–1292CrossRefPubMed Pickup JC, Mattock MB, Chusney GD, Burt D (1997) NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 40:1286–1292CrossRefPubMed
2.
go back to reference Spranger J, Kroke A, Mohlig M et al. (2003) Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes 52:812–817PubMed Spranger J, Kroke A, Mohlig M et al. (2003) Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes 52:812–817PubMed
3.
go back to reference Morishita E, Asakura H, Jokaji H et al. (1996) Hypercoagulability and high lipoprotein(a) levels in patients with type II diabetes mellitus. Atherosclerosis 120:7–14CrossRefPubMed Morishita E, Asakura H, Jokaji H et al. (1996) Hypercoagulability and high lipoprotein(a) levels in patients with type II diabetes mellitus. Atherosclerosis 120:7–14CrossRefPubMed
4.
go back to reference Leinonen E, Hurt-Camejo E, Wiklund O, Hulten LM, Hiukka A, Taskinen MR (2003) Insulin resistance and adiposity correlate with acute-phase reaction and soluble cell adhesion molecules in type 2 diabetes. Atherosclerosis 166:387–394CrossRefPubMed Leinonen E, Hurt-Camejo E, Wiklund O, Hulten LM, Hiukka A, Taskinen MR (2003) Insulin resistance and adiposity correlate with acute-phase reaction and soluble cell adhesion molecules in type 2 diabetes. Atherosclerosis 166:387–394CrossRefPubMed
5.
go back to reference Festa A, D’Agostino R, Tracy RP, Haffner SM (2002) Elevated levels of acute-phase proteins and plasminogen activator inhitor-1 predict the development of type 2 diabetes. The Insulin Resistance Atherosclerosis Study. Diabetes 51:1131–1137PubMed Festa A, D’Agostino R, Tracy RP, Haffner SM (2002) Elevated levels of acute-phase proteins and plasminogen activator inhitor-1 predict the development of type 2 diabetes. The Insulin Resistance Atherosclerosis Study. Diabetes 51:1131–1137PubMed
6.
go back to reference Berg AH, Combs TP, Du X, Scherer PE (2001) The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 7:947–953CrossRefPubMed Berg AH, Combs TP, Du X, Scherer PE (2001) The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 7:947–953CrossRefPubMed
7.
go back to reference Yokota T, Oritani K, Takahashi I et al. (2000) Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 96:1723–1732PubMed Yokota T, Oritani K, Takahashi I et al. (2000) Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 96:1723–1732PubMed
8.
go back to reference Spranger J, Kroke A, Mohlig M et al. (2003) Adiponectin and protection against type 2 diabetes mellitus. Lancet 361:226–228CrossRefPubMed Spranger J, Kroke A, Mohlig M et al. (2003) Adiponectin and protection against type 2 diabetes mellitus. Lancet 361:226–228CrossRefPubMed
9.
go back to reference Rimm EB, Williams P, Fosher K, Criqui M, Stampfer MJ (1999) Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors. BMJ 319:1523–1528PubMed Rimm EB, Williams P, Fosher K, Criqui M, Stampfer MJ (1999) Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors. BMJ 319:1523–1528PubMed
10.
go back to reference Carlsson S, Hammar N, Grill V, Kaprio J (2003) Alcohol consumption and the incidence of Type 2 diabetes: A 20-year follow-up of the Finnish twin cohort study. Diabetes Care 26:2785–2790PubMed Carlsson S, Hammar N, Grill V, Kaprio J (2003) Alcohol consumption and the incidence of Type 2 diabetes: A 20-year follow-up of the Finnish twin cohort study. Diabetes Care 26:2785–2790PubMed
11.
go back to reference Valmadrid CT, Klein R, Moss SE, Klein BE, Cruickshanks KJ (1999) Alcohol intake and the risk of coronary heart disease mortality in persons with older-onset diabetes mellitus. JAMA 282:239–246CrossRefPubMed Valmadrid CT, Klein R, Moss SE, Klein BE, Cruickshanks KJ (1999) Alcohol intake and the risk of coronary heart disease mortality in persons with older-onset diabetes mellitus. JAMA 282:239–246CrossRefPubMed
12.
go back to reference Solomon CG, Hu FB, Stampfer MJ et al. (2000) Moderate alcohol consumption and risk of coronary heart disease among women with type 2 diabetes mellitus. Circulation 102:494–499PubMed Solomon CG, Hu FB, Stampfer MJ et al. (2000) Moderate alcohol consumption and risk of coronary heart disease among women with type 2 diabetes mellitus. Circulation 102:494–499PubMed
13.
go back to reference Ajani UA, Gaziano JM, Lotufo PA et al. (2000) Alcohol consumption and risk of coronary heart disease by diabetes status. Circulation 102:500–505PubMed Ajani UA, Gaziano JM, Lotufo PA et al. (2000) Alcohol consumption and risk of coronary heart disease by diabetes status. Circulation 102:500–505PubMed
14.
go back to reference Tanasescu M, Hu FB, Willett WC, Stampfer MJ, Rimm EB (2001) Alcohol consumption and risk of coronary heart disease among men with type 2 diabetes mellitus. J Am Coll Cardiol 38:1836–1842CrossRefPubMed Tanasescu M, Hu FB, Willett WC, Stampfer MJ, Rimm EB (2001) Alcohol consumption and risk of coronary heart disease among men with type 2 diabetes mellitus. J Am Coll Cardiol 38:1836–1842CrossRefPubMed
15.
go back to reference Tanasescu M, Hu FB (2001) Alcohol consumption and risk of coronary heart disease among individuals with type 2 diabetes. Curr Diab Rep 1:187–191PubMed Tanasescu M, Hu FB (2001) Alcohol consumption and risk of coronary heart disease among individuals with type 2 diabetes. Curr Diab Rep 1:187–191PubMed
16.
go back to reference Clevidence BA, Reichman ME, Judd JT et al. (1995) Effects of alcohol consumption on lipoproteins of premenopausal women. A controlled diet study. Arterioscler Thromb Vasc Biol 15:179–184PubMed Clevidence BA, Reichman ME, Judd JT et al. (1995) Effects of alcohol consumption on lipoproteins of premenopausal women. A controlled diet study. Arterioscler Thromb Vasc Biol 15:179–184PubMed
17.
go back to reference Pellegrini N, Pareti FI, Stabile F, Brusamolino A, Simonetti P (1996) Effects of moderate consumption of red wine on platelet aggregation and haemostatic variables in healthy volunteers. Eur J Clin Nutr 50:209–213 Pellegrini N, Pareti FI, Stabile F, Brusamolino A, Simonetti P (1996) Effects of moderate consumption of red wine on platelet aggregation and haemostatic variables in healthy volunteers. Eur J Clin Nutr 50:209–213
18.
go back to reference Kiechl S, Willeit J, Poewe W et al. (1996) Insulin sensitivity and regular alcohol consumption: large, prospective, cross sectional population study (Bruneck study). BMJ 313:1040–1044PubMed Kiechl S, Willeit J, Poewe W et al. (1996) Insulin sensitivity and regular alcohol consumption: large, prospective, cross sectional population study (Bruneck study). BMJ 313:1040–1044PubMed
19.
go back to reference Albert MA, Glynn RJ, Ridker PM (2003) Alcohol consumption and plasma concentration of C-reactive protein. Circulation 107:443–447CrossRefPubMed Albert MA, Glynn RJ, Ridker PM (2003) Alcohol consumption and plasma concentration of C-reactive protein. Circulation 107:443–447CrossRefPubMed
20.
go back to reference Imhof A, Froehlich M, Brenner H, Boeing H, Pepys MB, Koenig W (2001) Effect of alcohol consumption on systemic markers of inflammation. Lancet 357:763–767CrossRefPubMed Imhof A, Froehlich M, Brenner H, Boeing H, Pepys MB, Koenig W (2001) Effect of alcohol consumption on systemic markers of inflammation. Lancet 357:763–767CrossRefPubMed
21.
go back to reference Agewall S, Wright S, Doughty RN, Whalley GA, Duxbury M, Sharpe N (2000) Does a glass of red wine improve endothelial function? Eur Heart J 21:74–78CrossRef Agewall S, Wright S, Doughty RN, Whalley GA, Duxbury M, Sharpe N (2000) Does a glass of red wine improve endothelial function? Eur Heart J 21:74–78CrossRef
22.
go back to reference Teragawa H, Fukuda Y, Matsuda K et al. (2002) Effect of alcohol consumption on endothelial function in men with coronary artery disease. Atherosclerosis 165:145–152CrossRefPubMed Teragawa H, Fukuda Y, Matsuda K et al. (2002) Effect of alcohol consumption on endothelial function in men with coronary artery disease. Atherosclerosis 165:145–152CrossRefPubMed
23.
go back to reference National Diabetes Data Group (1979) Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1039–1057PubMed National Diabetes Data Group (1979) Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1039–1057PubMed
24.
go back to reference Hu FB, Leitzmann MF, Stampfer MJ, Colditz GA, Willett WC, Rimm EB (2001) Physical activity and television watching in relation to risk for type 2 diabetes mellitus in men. Arch Intern Med 161:1542–1548CrossRefPubMed Hu FB, Leitzmann MF, Stampfer MJ, Colditz GA, Willett WC, Rimm EB (2001) Physical activity and television watching in relation to risk for type 2 diabetes mellitus in men. Arch Intern Med 161:1542–1548CrossRefPubMed
25.
go back to reference Rimm EB, Giovannucci EL, Stampfer MJ, Colditz GA, Litin LB, Willett WC (1992) Reproducibility and validity of a expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am J Epidemiol 135:1114–1126PubMed Rimm EB, Giovannucci EL, Stampfer MJ, Colditz GA, Litin LB, Willett WC (1992) Reproducibility and validity of a expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am J Epidemiol 135:1114–1126PubMed
26.
go back to reference Giovannucci E, Colditz G, Stampfer MJ et al. (1991) The assessment of alcohol consumption by a simple self-administered questionnaire. Am J Epidemiol 133:810–817 Giovannucci E, Colditz G, Stampfer MJ et al. (1991) The assessment of alcohol consumption by a simple self-administered questionnaire. Am J Epidemiol 133:810–817
27.
go back to reference Aderka D (1996) The potential biological and clinical significance of the soluble tumor necrosis factor receptors. Cytokine Growth Factor Rev 7:231–240CrossRefPubMed Aderka D (1996) The potential biological and clinical significance of the soluble tumor necrosis factor receptors. Cytokine Growth Factor Rev 7:231–240CrossRefPubMed
28.
go back to reference Hu FB, Manson JE, Stampfer MJ et al. (2001) Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med 345:790–797CrossRefPubMed Hu FB, Manson JE, Stampfer MJ et al. (2001) Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med 345:790–797CrossRefPubMed
29.
go back to reference U.S. Department of agriculture, Agriculture research service (1998) USDA Nutrient Database for Standard Reference, Release 12. U.S. Department of agriculture, Washington, D.C. U.S. Department of agriculture, Agriculture research service (1998) USDA Nutrient Database for Standard Reference, Release 12. U.S. Department of agriculture, Washington, D.C.
30.
go back to reference Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH (1997) Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336:973–979CrossRefPubMed Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH (1997) Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336:973–979CrossRefPubMed
32.
go back to reference Bruno G, Cavallo-Perin P, Bargero G, Borra M, D’Errico N, Pagano G (1996) Association of fibrinogen with glycemic control and albumin excretion rate in patients with non-insulin-dependent diabetes mellitus. Ann Intern Med 125:653–657PubMed Bruno G, Cavallo-Perin P, Bargero G, Borra M, D’Errico N, Pagano G (1996) Association of fibrinogen with glycemic control and albumin excretion rate in patients with non-insulin-dependent diabetes mellitus. Ann Intern Med 125:653–657PubMed
33.
go back to reference Jager A, van Hinsbergh VW, Kostense PJ et al. (2000) Increased levels of soluble vascular cell adhesion molecule 1 are associated with risk of cardiovascular mortality in type 2 diabetes: the Hoorn study. Diabetes 49:485–491PubMed Jager A, van Hinsbergh VW, Kostense PJ et al. (2000) Increased levels of soluble vascular cell adhesion molecule 1 are associated with risk of cardiovascular mortality in type 2 diabetes: the Hoorn study. Diabetes 49:485–491PubMed
34.
go back to reference Matsubara M, Maruoka S, Katayose S (2002) Decreased plasma adiponectin concentrations in women with dyslipidemia. J Clin Endocrinol Metab 87:2764–2769CrossRefPubMed Matsubara M, Maruoka S, Katayose S (2002) Decreased plasma adiponectin concentrations in women with dyslipidemia. J Clin Endocrinol Metab 87:2764–2769CrossRefPubMed
35.
go back to reference Pasceri V, Willerson JT, Yeh ET (2000) Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 102:2165–2168PubMed Pasceri V, Willerson JT, Yeh ET (2000) Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 102:2165–2168PubMed
36.
go back to reference Avogaro A, Tiengo A (1993) Alcohol, glucose metabolism and diabetes. Diabetes Metab Rev 9:129–146PubMed Avogaro A, Tiengo A (1993) Alcohol, glucose metabolism and diabetes. Diabetes Metab Rev 9:129–146PubMed
Metadata
Title
Moderate alcohol intake and markers of inflammation and endothelial dysfunction among diabetic men
Authors
I. Shai
E. B. Rimm
M. B. Schulze
N. Rifai
M. J. Stampfer
F. B. Hu
Publication date
01-10-2004
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 10/2004
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-004-1526-0

Other articles of this Issue 10/2004

Diabetologia 10/2004 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.